ARCHIVES

Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction

This article is from The Cancer Letter archive.

Vol. 14 No. 28 | July 8, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976